Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema
Main Authors: | Arvind Kumar Dubey, Kaustubh Balwant Harshey |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Indian Journal of Ophthalmology |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2016;volume=64;issue=1;spage=96;epage=96;aulast=Dubey |
Similar Items
-
Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema: A prospective, randomized comparative study
by: Murat Kucukevcilioglu, et al.
Published: (2015-01-01) -
Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study
by: Seemant Raizada, et al.
Published: (2015-01-01) -
Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
by: Hideaki Someya, et al.
Published: (2019-01-01) -
Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Refractory Diffuse Diabetic Macular Edema
by: Mohammad-Hossein Dehghan, et al.
Published: (2010-01-01) -
Pars Plana Vitrectomy versus Intravitreal Injection of Ranibizumab in the Treatment of Diabetic Macular Edema Associated with Vitreomacular Interface Abnormalities
by: Hassan Elkayal, et al.
Published: (2021-01-01)